ProCE Banner Activity

(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Tool

Learn how 5 experts incorporate the latest evidence on (neo) adjuvant therapy into the management of HER2-negative breast cancer using this Interactive Decision Support Tool.

Released: September 06, 2022

Expiration: September 05, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner

Additional Information

Program Medium

This program has been made available online.